Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-15 to 2024-07-16
Current total value of award: $2280.55
Description: 4565160166!QUILLIVANT XR 25 MG/5 ML SUSP 120ML